Abstract. Serum immunoreactive erythropoietin (siEPO) was determined in cord serum from neonates (n = 97, gestational age 36-43 weeks), in healthy children from birth to adolescence (n = 260) and in children with haematological (n = 30), renal (n = 10) and congenital heart diseases (n = 70). In healthy children siEPO levels decreased after birth (geometric mean cord siEPO 35.6mU/ml with 95% range of 17-56mU/ml in eutrophic, nondistressed fetuses) and reached lowest values during the first 2 months (geometric mean siEPO ll.5mU/ ml). Thereafter siEPO levels increased slightly and were constant between 2 months and adolescence. The geometric mean siEPO for healthy children after birth was 18.8mU/ml with 95% range of 7-47 mU/ml. These estimates were not significantly different from normal adult values. In newborns with fetal distress (n = 15) cord siEPO was significantly elevated (geometric mean 63.0 mU/ml; P < 0.001). In children with haematological disease, siEPO and Hb concentration were inversely correlated (log siEPO (mU/ml)= 4.1 -0.20 x Hb (g/dl); r=-0.62; P<0.0005). This relationship was significantly different in children with chronic renal failure (log siEPO (mU/ml) = 0.67 + 0.035 • Hb (g/dl); r = 0.50; P = 0.1). In children with heart disease the geometric mean siEPO was 19.2mU/ml with 95% range 8-65 mU/ml for cyanotic (SaO2 < 94%) and 17.7 mU/ml with 95% range of 12-36 mU/ml for acyanotic patients. In this group siEPO values were inversely correlated to the arterial oxygen content (log siEPO (mU/ml) = 1.61 -2.04 x oxygen content (1/t); r = -0.28; P < 0.02).
Introduction
Erythropoietin (EPO) is considered the primary regulator of red cell formation [20] . The development of sensitive radioimmunoassays for the estimation of EPO allows the routine measurement of the hormone in biological fluids. In order to determine whether disorders of erythropoiesis are related to inappropriate EPO production, normal values and their alter-
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Abbreviations: EPO = erythropoietin; siEPO = serum immunoreactive erythropoietin ations in different diseases must be established. In adults normal serum values and the physiological relationship of serum EPO levels to Hb concentration are well known [2, 5, 7, 8, 10, [16] [17] [18] 24] . Less information is available, however, on EPO levels in childhood. Only recently have values from healthy children between birth and 16 years been reported [12] . In previous studies in children with conditions such as prematurity, cardiopulmonary, haematological and renal disorders [1, 3, 4, 11, 15, 19, 22] , estimates were generally related to adult levels because values in normal children were not available. It was the intention of this study to determine the age and sex distribution of serum EPO concentrations in healthy children between birth and adolescence. Furthermore, we studied the relationship of serum EPO levels to arterial oxygen content in children with haematological, renal and congenital heart diseases and compared these parameters with those of healthy infants.
Subjects and methods
The study was carried out according to the principles of the Declaration of Helsinki.
Newborns
Cord serum samples were obtained immediately after birth from 97 consecutively delivered neonates (gestational age 36-43 weeks). Eight of these newborns suffered from intrauterine hypothrophy. Fifteen newborns had signs of fetal distress, when defined as i min Apgar score below 7 or umbilical artery pH below 7.2.
Healthy children
Serum samples of 260 healthy children (age 1 day-15 years) and 14 adolescents (age 16-20 years) were available for analysis. All children and adolescents participated in a growth study with the informed consent of the parents and the ethical committee of the University of Ulm, Federal Republic of Germany.
Adult controls
For comparison, serum immunoreactive erythropoietin (siEPO) levels were also determined in 84 adults (age range 21-87 years) with their informed consent. These were either members of laboratory staff or medical in-patients for elective eye surgery. None suffered from a haematological, cardiopulmonary or renal disease, as confirmed by case history and routine laboratory tests.
Children with haematological disorders
SiEPO was measured in 30 children (age 2-16 years) with anaemias of various aetiologies. In 15 patients anaemia was due to an aregenerative bone marrow, including severe aplastic anaemia, pure red cell aplasia and Blackfan Diamond disease. The other 15 children suffered from 13-thalassaemia and were periodically transfused every 3 to 4 weeks. All children had normal renal function. None had received transfusions for at least 2 weeks prior to blood sampling for determination of serum EPO. Arterial oxygen content was calculated from Hb concentrations (see below) assuming 97% SaO2.
Children with renal failure
Ten patients with renal failure were investigated (age 2-16 years). One had acute renal failure due to haemolytic uraemic syndrome, and nine suffered from chronic renal failure of various aetiologies (two cases each with nephronophthisis, obstructive uropathy and glomerulonephritis, and one case each with congenital renal hypoplasia, Alport syndrome and interstitial nephritis). Glomerular filtration rate ranged from 7 to 55 ml/min with a mean of 26 ml/min. None of these children received recombinant EPO or had undergone renal transplantation.
Children with congenital heart disease
Seventy patients with various forms of congenital heart disease were studied (age 3 days-16 years). These included 32 patients with single malformations (atrial or ventricular septal defect, persistent ductus arteriosus, pulmonary or aortic valve stenosis, hypoplastic left ventricle and transposition or great arteries) and 38 patients with complex vitia. All patients had normal serum creatinine values. Cyanosis was considered present if SaO2 was less than 94% and absent if -94%. Arterial oxygen content was calculated as follows: SaO2 • Hb (g/ dL) • 1.34.
Radioirnmunoassay for EPO
SiEPO was determined by radioimmunoassay exactly as described [6] . In brief, 100 gl samples plus 20 gl of 30% bovine serum albumin were incubated with 100 gl rabbit antiserum raised against recombinant human EPO for 24h. 100 btl of tracer (8 x 10-11mol/1 125I EPO; Amersham International, Amersham, UK) were then added and after an additional incubation period of 24 h free and bound ligand were separated using a second antibody technique. As a standard we used the 2nd International Reference Preparation of human urinary EPO (WHO).
Data evaluation and statistics
Since serum EPO levels were approximately log-normally distributed (see results), EPO levels were log-transformed for plotting and calculations and geometric means were calculated for groups of observations. Unpaired Student t-test was used for comparison of groups and analysis of variance to determine significance levels of linear regressions. A P-value < 0.05 was considered to be significant.
Results

Healthy children
SiEPO concentrations of 260 healthy children (age 1 day-15 years) ranged from 5 to 95 mU/ml. The geometric mean was 18.8mU/ml and the 95% range 7-47mU/ml. Only two children had siEPO levels higher than 54 mU/ml and were therefore analysed separately. The frequency distribution of siEPO for the remaining 258 children (131 boys and 127 girls) is shown in Fig. 1 . After log-transformation, siEPO values in boys and girls were approximately normally distributed. There was no sex difference for the whole group (geometric mean 18.6 mU/ml for boys and 18.8 mU/ml for girls) or at any age. Figure 2 shows the distribution of siEPO values in relation to age for (i) the above 258 healthy children, (ii) 75 nondistressed, eutrophic newborns (cord siEPO), (iii) healthy adolescents (n = 14; age range 16-20 years; geometric mean 21.4 mU/ml; 95% range from 13 to 36 mU/ml) and (iv) normal adults (n = 84; geometric mean 17.9mU/ml; 95% range from 11-31 In younger infants estimates of siEPO were different. In cord blood of healthy newborns we found a geometric mean of 35.6 mU/ml (95% range 17-56 mU/ml), which was significantly higher than in children after birth (P < 0.001). In children aged 1 day to 2 months, geometric mean siEPO was 11.5 mU/ ml (95% range 5-53 mU/ml; n = 18) and significantly lower than in older children (P < 0.05). Individual values for children in this group are given in Table 1 .
In two girls (10 and 11 years old, respectively), who were primarily included in the group of healthy children, siEPO levels were higher than in the other children (79 and 95 mU/ ml, respectively). No obvious reason for the increased levels was apparent from clinical and laboratory data. 
Hypotrophic newborns and newborns with signs of fetal distress
In hypotrophic newborns median gestational age was 37 weeks (range 36-38weeks) and median birth weight was 2150 g (range 1720-2350 g). Geometric mean cord siEPO in these children was 29.9 mU/ml (95% range 17-56 mU/ml) and not significantly different from eutrophic neonates with normal umbilical artery pH and Apgar score (P > 0.20).
In newborns with signs of fetal distress, defined as either i min Apgar score below 7 or umbilical artery pH below 7.2, median 1 min Apgar score was 7 (range 3-9) and median umbilical artery pH 7.18 (range 7.13-7.27). Geometric mean cord siEPO in this group was 63.0mU/ml (95% range 17-331 mU/ml; P<0.001 vs eutrophic, nondistressed newborns). Furthermore, when values from all newborns were analysed together, a slight but statistically significant inverse correlation was found between umbilical artery pH and cord siEPO (log siEPO (mU/ml) = 7.9 -0.87 • pH; r = -0.21, P < 0.05). In addition, in the whole group of neanates cord siEPO increased with gestational age (log siEPO (mU/ml)= -0.8 + 0.06 • gest. age (weeks); r = 0.33, P< 0.002) (Fig. 3) .
Anaemic children
A relationship of siEPO to Hb concentrations was discovered in blood samples obtained from anaemic children with bone marrow aplasia and thalassaemia (Fig. 4) . The children of this group were aged between 2 and 16 years (mean 8.2 years). SiEPO ranged between 14 and 6000 mU/ml, and Hb between 4 and 13 g/dl. SiEPO and Hb concentration were inversely correlated and showed a negative linear regression when plotted on a semilogarithmic scale (log siEPO (mU/ml)= 4.1-0.20• Hb (g/dl); r=-0.62; P<0.0005) (Fig. 3) . This relationship of siEPO to Hb was significantly different in a group of anaemic children suffering from renal disease (log siEPO (mU/ml) = 0.67 + 0.035 • Hb (g/dl); r = 0.50; P = 0.1) (Fig. 5) . This group consisted of 10 uraemic children aged between 2 and 16 years. SiEPO values remained low even during severe anaemia.
The relationship of siEPO to Hb was also altered in healthy children during the 1st trimenon (Fig. 5 ). It appears that the values in healthy children during the 1st trimenon are at the lower limit of those obtained in children with haematological diseases. 
Children with heart disease
We determined siEPO in 70 children with congenital heart disease, aged between 3 days and 16 years (mean 3.5 years). Fifty of them were cyanotic (SaOz<94%). The geometric mean of siEPO was 19.2 mU/ml and the 95% range from 8 to 65 mU/ml for the cyanotic children. For the acyanotic chil-dren, the geometric mean was 17.7 mU/ml and the 95% range from 12 to 36 mU/ml. The difference between cyanotic and acyanotic children was not significant. SiEPO was neither correlated with Hb nor with SaO2. An inverse correlation, however, was observed between siEPO and arterial oxygen content (log siEPO (mU/ml) = 1.61 -2.04 x oxygen content (1/1); r = -0.28; P< 0.02). It is evident from Fig. 6 that the data obtained from children with heart disease and those obtained from healthy children and children with haematological disease fit a consistent relationship of siEPO to arterial oxygen content.
Discussion
Our observation that siEPO concentrations in healthy children between 2 months of age and adolescence were not significantly different from those of healthy adults confirms previous results by Hellebostad et al. [12] . We also found no sex differences nor significant changes of siEPO during puberty (Figs. 1, 2) . The latter finding could indicate that the expansion or red cell mass during accelerated body growth is not primarily triggered by EPO. It supports the concept that the adaptation of red cell mass to body mass during growth is controlled by other factors such as insulin-like growth factor I [14] .
SiEPO values in cord blood were significantly higher than serum levels during childhood and showed considerable variation (Fig. 2) . The magnitude of cord serum values in our study is comparable to that reported by Thomas et al. [21] . These results extend previous investigations, that demonstrated erythropoietic activity in cord blood and 1st day urine, but not during the following weeks by employing less sensitive bioassays for EPO [9] . In addition to Thomas and coworkers, who demonstrated an increase in EPO levels from 19 weeks gestation until term [21] , we found a significant increase also during late gestation (Fig. 3) . The importance of EPO for the regulation of fetal erythropoiesis is further supported by previous studies, demonstrating increased EPO levels in the presence of placental insufficiency and fetal hypoxia [9, 21, 23] . Also in the present investigation EPO levels in children with signs of fetal distress were elevated and cord blood EPO was inversely correlated with umbilical artery pH, indicating that fetal EPO production can respond to hypoxia.
During the 1st trimenon, when an anaemia develops, rather low siEPO values were found. The same observation was made by Hellebostad et al. [12] and may indicate that the physiological feedback loop between oxygen delivery and EPO production-well established for adults [8] -is less sensitive during the 1st trimenon. The idea is supported by our observation that the relationship of siEPO to Hb during the first 3 months was in the lower range of that obtained from older children with haematological diseases (Fig. 5) . This also complies with the observation made by Brown et al. [3, 4] that in premature infants there is a decreased response of EPO production to available oxygen.
The inverse relationship of siEPO to Hb, which we found in children with haematological disorders, agrees with the results obtained by McGonigle et al. [15] and was almost identical with that of adult patients [8, 17] . This finding suggests that the feedback loop of EPO production as known from adults is already established during the first years of life. Due to the relatively small number of haematological patients in our study it was not possible to clearly distinguish whether the relationship of siEPO to Hb is different during ineffective and aregenerative erythropoiesis as suggested by two other studies [15, 19] . As in adults the relationship of siEPO to Hb was significantly altered in children with renal failure and their anaemia was accompanied by inappropriate low levels of siEPO (Fig. 4) . Inappropriate low EPO levels in uraemic children have also been observed in another study [1] . Both studies thus indicate indirectly that the kidneys are the physiological production site of EPO already during childhood.
The observation that siEPO levels in children with heart disease are not significantly different from those in healthy children are in accordance with previous reports [11, 22] . On first glance it may be surprising that there is no difference in siEPO between cyanotic and acyanotic children and that, in contrast to anaemic children, there is no correlation of siEPO to Hb concentrations. However, EPO production is in general inversely related to renal oxygen supply [13] . In states of unphysiological oxygen saturation therefore siEPO should be inversely related to the arterial oxygen content rather than to the Hb concentration. In fact, such a relationship was seen in this and two other studies [11, 22] . Moreover, we found that a consistent relationship of siEPO to arterial oxygen content resulted when the data from healthy children and children with haematological and heart diseases were combined (Fig. 6) . Thus the lack of abnormal siEPO values during heart disease appears to result from a very fine tuning of the feedback loop of EPO production.
